1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections

BACKGROUND: Clinical trials of new antibacterial agents in patients with carbapenem-resistant infections are critical but challenging to conduct. One challenge is identifying the study population by microbiological (micro) criteria; patients need to be identified locally to initiate effective treatm...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Open Forum Infect Dis
Главные авторы: Kaye, Keith, File, Thomas, Boucher, Helen W, Brown, Michelle, Aggrey, Angela, Khan, Ireen, Joeng, Hee-Koung, Tipping, Robert, Du, Jiejun, Young, Katherine, Butterton, Joan, Kartsonis, Nicholas A, Paschke, Amanda
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254124/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1171
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы